Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy.
about
Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending ToxinSensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin.Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems.Zinc oxide nanoparticles impair bacterial clearance by macrophages.Heparin: new life for an old drug.
P2860
Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development of chitosan/hepari ...... in for gastric cancer therapy.
@ast
Development of chitosan/hepari ...... in for gastric cancer therapy.
@en
Development of chitosan/hepari ...... in for gastric cancer therapy.
@nl
type
label
Development of chitosan/hepari ...... in for gastric cancer therapy.
@ast
Development of chitosan/hepari ...... in for gastric cancer therapy.
@en
Development of chitosan/hepari ...... in for gastric cancer therapy.
@nl
prefLabel
Development of chitosan/hepari ...... in for gastric cancer therapy.
@ast
Development of chitosan/hepari ...... in for gastric cancer therapy.
@en
Development of chitosan/hepari ...... in for gastric cancer therapy.
@nl
P2093
P2860
P356
P1433
P1476
Development of chitosan/hepari ...... in for gastric cancer therapy.
@en
P2093
Cheng-Kuo Lai
Chih-Ho Lai
Chun-Lung Feng
Hong-Lin Su
Jer-Tsong Hsieh
Pei-Ching Tsai
Shih-Chang Tsai
Yu-Hsin Lin
Yu-Luen Lu
Yuh-Shyan Tsai
P2860
P304
P356
10.2217/NNM.13.54
P577
2013-09-11T00:00:00Z